Vitro Signs Settlement Agreements With All Derivative Counterparties

Date: 15 September 2010
Source: Vitro

Date: 15 September 2010

San Pedro Garza García, Nuevo León, México, September 7, 2010 - Vitro S.A.B. de C.V. (“Vitro” or the “Company”) (BMV: VITROA) announced today that it has signed settlement agreements (the “Settlements”) with all derivative counterparties.

As previously announced, Vitro reached an agreement to settle the amount related to derivative financial instruments (“DFIs”) with Calyon, London Branch (“Calyon”). In addition, the Company reached a settlement agreement with Fintech Investments Ltd. (“Fintech”), the firm that recently acquired the DFIs claims, previously owned by Credit Suisse International, Deutsche Bank AG, London Branch, Merrill Lynch Capital Services, Citibank, N.A., Barclays Bank, PLC and Cargill, Incorporated. The amount of the settlement agreed with Calyon and Fintech is US$63.4 MM and US$176.9 MM, respectively, for a total amount of US$240.3 MM recognized by the Company. As a result of these Settlements, all of the lawsuits related with the DFIs have been dismissed. Vitro remains committed to a consensual restructuring process and is working diligently to finalize and launch its Consent Solicitation as quickly as possible.San Pedro Garza García, Nuevo León, México, September 7, 2010 - Vitro S.A.B. de C.V. (“Vitro” or the “Company”) (BMV: VITROA) announced today that it has signed settlement agreements (the “Settlements”) with all derivative counterparties.
 
As previously announced, Vitro reached an agreement to settle the amount related to derivative financial instruments (“DFIs”) with Calyon, London Branch (“Calyon”).
 
In addition, the Company reached a settlement agreement with Fintech Investments Ltd. (“Fintech”), the firm that recently acquired the DFIs claims, previously owned by Credit Suisse International, Deutsche Bank AG, London Branch, Merrill Lynch Capital Services, Citibank, N.A., Barclays Bank, PLC and Cargill, Incorporated.
 
The amount of the settlement agreed with Calyon and Fintech is US$63.4 MM and US$176.9 MM, respectively, for a total amount of US$240.3 MM recognized by the Company.
 
As a result of these Settlements, all of the lawsuits related with the DFIs have been dismissed.
 
Vitro remains committed to a consensual restructuring process and is working diligently to finalize and launch its Consent Solicitation as quickly as possible.

600450 Vitro Signs Settlement Agreements With All Derivative Counterparties glassonweb.com

See more news about:

Others also read

Vitro Architectural Glass is pleased to announce one of its newest products, Sungate ThermL™ glass, was named one of the “Top 75 Products of 2024” by Building Design + Construction (BD+C).
Vitro Architectural Glass is pleased to announce that its refined VacuMax™ Vacuum Insulating Glass (VIG) was honored by Architectural Record as one of the Best Architectural Products of 2024.
Vitro Architectural Glass is pleased to announce that Mark Seeton, Vice President of Sales, has been appointed to the National Glass Association (NGA) Board of Directors.
Vitro Architectural Glass, renowned as the largest glass manufacturer in North America, is pleased to announce the appointment of Matthew Pryor as Commercial Account Manager of the Texas region.
Vitro Architectural Glass is pleased to announce that its energy-efficient, low-embodied carbon glass is featured in eight award-winning projects recognized by the American Institute of Architects (AIA).
Mississippi’s first dedicated children’s hospital, the Sanderson Tower, combines advanced care and modern design with Vitro’s Solarban® 90 glass for a bright, welcoming space.

Add new comment

From industry

NEWS RELATED PRODUCTS

Vitro Architectural Glass
Vitro Architectural Glass
Vitro Architectural Glass
Vitro Architectural Glass
Vitro Architectural Glass
Vitro Architectural Glass